Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-29 @ 11:53 AM
Study NCT ID:
NCT04677595
Status:
COMPLETED
Last Update Posted:
2025-06-24
First Post:
2020-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-18
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-23
Last Update Post Date:
2025-06-24
Last Update Post Date Type:
ACTUAL